Literature DB >> 2032317

IgA anti-gliadin antibodies in adult celiac disease.

P G Hill1, S P Thompson, G K Holmes.   

Abstract

We have improved the enzyme-linked immunosorbent assay for IgA-class antibodies to gliadin in serum by evaluating earlier publications. We also assess the value of measuring these antibodies when screening for adult celiac disease and monitoring dietary compliance. Of 61 adults with untreated celiac disease, 57 had abnormal results, giving a sensitivity for the test of 0.93. Patients (n = 283) attending a gastroenterology clinic formed the control group. The predictive values of positive results and negative results were 50% and 99.7%, respectively, indicating that the test has a role in helping select those subjects in whom small bowel biopsy is indicated. Adults with celiac disease, after two years on a strict gluten-free diet, and normal subjects showed no significant difference in serum IgA-class anti-gliadin antibody concentrations. The test thus provides objective evidence of dietary compliance in addition to its role as a screening test.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2032317

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

Review 1.  Recent advances in coeliac disease.

Authors:  D A van Heel; J West
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

2.  Effectiveness of antigliadin antibodies as a screening test for celiac disease in children.

Authors:  L J Chartrand; J Agulnik; T Vanounou; P A Russo; P Baehler; E G Seidman
Journal:  CMAJ       Date:  1997-09-01       Impact factor: 8.262

3.  Lack of cellular and humoral immunological responses to oats in adults with coeliac disease.

Authors:  E K Janatuinen; T A Kemppainen; P H Pikkarainen; K H Holm; V M Kosma; M I Uusitupa; M Mäki; R J Julkunen
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

4.  Coeliac disease in the elderly.

Authors:  G L Hankey; G K Holmes
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

5.  Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values.

Authors:  G Corrao; G R Corazza; M L Andreani; P Torchio; R A Valentini; G Galatola; D Quaglino; G Gasbarrini; F di Orio
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

Review 6.  The serological diagnosis of coeliac disease - a step forward.

Authors:  Geoffrey Holmes; Carolina Ciacci
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.